Loading...
XBKK
PR9
Market cap490mUSD
Nov 12, Last price  
20.80THB
Name

Praram 9 Hospital PCL

Chart & Performance

D1W1MN
XBKK:PR9 chart
P/E
19.88
P/S
3.10
EPS
1.05
Div Yield, %
1.44%
Shrs. gr., 5y
Rev. gr., 5y
15.20%
Revenues
5.28b
+13.83%
1,777,003,0761,960,256,0652,238,341,9272,421,499,1652,701,078,2372,848,520,0472,601,207,7652,986,783,2554,107,342,3624,201,969,8624,635,381,1485,276,567,599
Net income
823m
+15.44%
162,158,820193,594,409259,813,338262,255,738157,225,594284,457,249202,054,814249,168,996567,610,505557,859,853712,682,373822,709,359
CFO
1.05b
+0.68%
00388,039,885442,259,158479,583,401490,035,676423,771,804588,020,895892,542,740804,071,4921,039,878,4141,046,970,156
Dividend
Apr 30, 20260.3 THB/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Praram 9 Hospital Public Company Limited manages Praram 9 Hospital, a prominent medical institution located in Thailand. This facility delivers a broad spectrum of tertiary healthcare services, encompassing health promotion, preventative medicine, thorough diagnosis, effective treatment, and comprehensive rehabilitation. Its core medical specialties include obstetrics and gynecology, general surgery, internal medicine, pediatrics, advanced kidney transplantation, cardiovascular care, and orthopedics. The hospital further distinguishes itself with numerous specialized centers, addressing areas such as diabetes and metabolic conditions, gastroenterology and hepatobiliary issues, neurological disorders, routine health check-ups, urgent care, physical therapy and rehabilitation, advanced imaging (radiology), ophthalmology, otolaryngology (ear, nose, and throat), dentistry, mental well-being, dermatology and cosmetic procedures, breast health, joint care, spinal conditions, allergy management, oncology, sleep disorders, pulmonary and respiratory diseases, wellness programs, and LASIK eye surgery. Established in 1992, the company maintains its primary base of operations in Bangkok, Thailand.
IPO date
Oct 30, 2018
Employees
Domiciled in
TH
Incorporated in
TH

Valuation

Title
THB in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT